PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sector of biopharmaceuticals, offering promising breakthroughs throughout different clinical and industrial programs. With its structural similarity to Normally derived human serum albumin, OsrHSA provides a safer, more reputable choice for therapeutic use, speci